Curium deepens radiopharma heft with up to $8 billion deal for Lantheus

By Kamal Choudhury and Kunal Das Aug 3 (Reuters) – Radiopharmaceutical company Curium has agreed to buy peer Lantheus Holdings in a deal worth up to $8 billion, as the private equity-backed firm looks

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)